OIP — The Opportunity Intelligence PlatformUniversal opportunity detail
OIP is retrieving the stored public projection, source provenance, warnings, evidence, and review steps for this opportunity.
OIP / Universal opportunity detail
IndieBio from SOSV / IndieBio. Startup development program support, infrastructure, technical/regulatory/commercial expertise, and SOSV investment process.
OIP shows the benefit, deadline, fit signals, uncertainty, and source trail in one place. The official source still controls eligibility, instructions, deadlines, and restrictions.
Open the official source and verify eligibility, deadline, benefit restrictions, required materials, and current status before acting.
Opportunity overview
Benefit separation
Objective OIP score
OIP surfaced this Startup and Accelerator record with an objective score of 66/100 based on public projection fields.
This score helps prioritize review of the opportunity record. It is not a promise of eligibility, funding, revenue, investment, or success.
8 warnings. Published with warnings.
Warnings and uncertainty
Award value is forecast or unconfirmed. Eligibility is preliminary and should be confirmed against final official terms. OIP does not imply acceptance likelihood, fundraising success, or investment returns. OIP does not imply program endorsement. Specific investment amount and cohort dates require official review. Users must verify eligibility, application status, equity, fees, relocation, and participation obligations on the official source before applying. Investment, equity, or ownership terms require official-source review. Non Cash Benefit Not Cash Funding Published with warnings
Source and trust
Same opportunity confirmed. Primary active public projection.
Evidence
SOSV / IndieBio
Startup and Accelerator Official Registry (Capital Intelligence)
Startup Support; source type: IndieBio
Infrastructure Credit, Accelerator Support, Mixed Support
No unrestricted cash value stated
Startup development program support, infrastructure, technical/regulatory/commercial expertise, and SOSV investment process.
Rolling
Rolling; rolling deadline requires current official-source review
Startup, At Least Two-Person Team Preferred For SOSV Programs
Global applicants; IndieBio locations include New York and San Francisco.
tier_1_official_primary
Official URL available
Domain context
Before acting